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Abstract 
Purpose: To investigate the influence of the lipid profile and related parameters on the development of 
asthma in children aged 10 to 15 years. 
Methods: Peripheral blood samples were collected from a group diagnosed with asthma as well as 
from a healthy control group. The lipid profile parameters measured were total cholesterol (TC), 
triglycerides (TG), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density 
lipoprotein (HDL), serum total antioxidant capacity (TAC), reduced glutathione (GSH), and 
malondialdehyde (MDA), and the activities of lecithin–cholesterol acyltransferase (LCAT) and 
cholesteryl ester transfer protein (CETP). 
Results: TC, TG, LDL, and VLDL levels were significantly (p ≤ 0.05) higher in the asthma group 
compared with the controls, while HDL level was lower. Total TAC and GSH were lower in the asthma 
group, while MDA level, and LCAT and CETP activities were higher. 
Conclusion: There is a link between an elevated lipid profile and increased antioxidant capacity in 
asthmatic children. 
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Asthma is a heterogeneous disease that 
affects both children and adults, and is 
characterized by chronic inflammation in 
the respiratory tract due to continuous 
inflammatory stress signaling or chronic 
exposure to allergens [1]. Symptoms of 
asthma include wheezing, shortness of 
breath, tightness in the chest, and cough 
of varying intensity [1]. Asthma is a 
chronic health problem that affects 20 % 
of children worldwide [2]. Globally, 
asthma-related problems have increased 
by 30 % over the past 20 years [3]. 
 
Measurement of the nitric oxide 
concentration in exhaled breath is a non-
invasive method of monitoring the status 
of airway inflammation due to asthma in 
children older than 1 year [4]. Any 
infection in the upper respiratory tract 
with recurrent coughing and wheezing, 
followed by an elevated concentration of 
exhaled nitric oxide for more than 4 
weeks, is taken as a clinical marker of 
asthma in children [5,6]. 
 
Reports suggest a strong correlation 
between oxidative stress and lung 
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diseases, including asthma, chronic 
obstructive pulmonary disorder, cystic 
fibrosis, and lung cancer [7]. In the body, 
oxidative stress is mitigated by the 
antioxidant system, which consists of 
enzymatic and non-enzymatic 
antioxidants [8]. Failure of the 
antioxidant defense system can result in 
oxidant-mediated injury, leading to cell 
death [8]. Acute asthma exacerbations 
may lead to increased oxidative stress, 
which in turn causes reduced superoxide 
dismutase (SOD) activity [9]. It has been 
reported that extracellular glutathione 
(GSH) peroxidase activity is increased in 
the bronchial epithelial cells of asthmatic 
subjects [10,11]. Superoxide and 
hydrogen peroxide radicals also increase 
vascular endothelial growth factor 
expression, which can be blocked by 
antioxidants [12]. 
 
Advances in the diagnosis of asthma 
have led to both under- and over-
diagnosis of the disease [2]. Under-
diagnosis could lead to an increased 
burden and higher healthcare costs, 
while over-diagnosis could lead to higher 
treatment costs and exposure to 
unwanted side-effects. Globally, nearly 
one-third of all children and adolescents 
are classified as either overweight or 
obese and show abnormal lipid profiles 
[13]. Therefore, it is very important to 
identify correlations among the clinical 
parameters and markers that can help to 
diagnose asthma accurately. This study 
examined the correlations between 
asthma in children and the lipid profile 
and related blood parameters, with the 
aim being to identify factors that favor 





Study design and subjects 
 
Children between 10 and 15 years of 
age, and presenting to Jining No. 1 
People’s Hospital, Shandong, China for 
asthma treatment, were initially screened 
for symptoms of asthma using a 
standard protocol. Children diagnosed 
with asthma were selected randomly for 
inclusion in the study. The study 
objectives, experimental design, and 
protocol were explained to the subjects 
in the presence of their parents or legal 
guardians, from whom written consent 
was obtained. Age, sex, height (m), and 
weight (kg) data were collected. The 
body mass index (BMI) of the subjects 
was calculated using the standard 
formula (kg/m2). The study matched 59 
children (28 boys, 31 girls) in the asthma 
group by age and gender with 57 (29 
boys, 28 girls) children in the control 
group. After a minimum 10-h fast, 7 mL 
of venous blood was collected from each 
subject. Serum was prepared from the 
blood samples in a refrigerated table-top 
centrifuge and stored at –80 °C until 
analysis. The experiment was approved 
by the Ethical Review Committee of the 
Jining No.1 People’s Hospital (approval 
Ref no 1603312) complied with 
international guidelines [14]. 
 
Determination of lipid profile parameters 
 
The total cholesterol (TC), high-density 
lipoprotein (HDL) cholesterol and 
triglycerides (TG) were assayed using 
commercial kits (BioSino Bio-technology 
and Science, Shanghai, China), 
following the manufacturer’s instructions. 
Low-density lipoprotein (LDL) cholesterol 
was calculated from the measured TC, 
TG, and HDL cholesterol using the 
following formula: LDL-cholesterol = 
total-cholesterol – HDL-cholesterol – 
[TG/5], where [TG/5] is an estimate of 
very-low-density lipoprotein (VLDL) 
cholesterol; all values are in mg/dL [15]. 
 
CETP and LCAT assays 
 
The CETP and lecithin–cholesterol 
acyltransferase (LCAT) activities were 
assayed in serum using commercial 
fluorometric assay kits (Roar Biomedical, 
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New York, NY, USA). Buffers and 
reagents were used as provided, and the 
standard assay protocol followed the 
manufacturer’s instructions. CETP 
Activity Assay Kit uses a proprietary 
substrate that enables the detection of 
CETP-mediated transfer of neutral lipid 
from the substrate to a physiological 
acceptor. The transfer activity results in 
an increase in fluorescence intensity. 
LCAT activity was obtained by a 
fluorometric assay that measures the 
phospholipase activity of LCAT. 
 
Determination of the total antioxidant 
capacity of serum 
 
The total antioxidant capacity (TAC) of 
the serum was measured based on a 
colorimetric method developed by Erel 
[16]. The assay mixture consists of 
ferrous ion solution and hydrogen 
peroxide, which produce hydroxyl 
radicals that generate brown dianisidinyl 
radical cations. The antioxidant capacity 
of the serum was measured against the 
potent free radical reactions initiated by 
the hydroxyl radicals produced. The 
assay results are expressed in mM of 
Trolox equivalents/L. 
 
Evaluation of serum reduced glutathione 
 
Reduced GSH in serum was analyzed 
using the method of Ellman et al [17] and 
expressed in mg/dL. This enzymatic 
recycling method uses GSH reductase to 
quantify GSH. The sulfhydryl group of 
GSH reacts with 5,5'-dithio-bis-2-
nitrobenzoic acid (Ellman’s reagent) and 
produces yellow 5-thio-2-nitrobenzoic 
acid (TNB). Oxidized glutathione 
(GSSG) is then reduced to GSH by GSH 
reductase, using reducing equivalents 
provided by NADPH. The rate of TNB 
formation is proportional to the sum of 
GSH and GSSG present in the sample, 
determined by measuring the formation 
of TNB at 412 nm. 
 
Serum malondialdehyde levels  
 
Malondialdehyde (MDA) in serum was 
analyzed using the method of Ohkawa et 
al [18]. Briefly, serum was reacted with 
trichloroacetic acid containing 2-
thiobarbituric acid, and the mixture was 
incubated at 95 °C for 20 min and then 
cooled in ice. The thiobarbituric acid 
content was measured as the MDA (ε = 
155 mM−1cm−1) content at A532 using a 





All group data are presented as mean ± 
SD. Significant differences between the 
groups were analyzed using one-way 
analysis of variance followed by Tukey’s 
honestly significant difference post-hoc 





Table 1 summarizes the subjects’ characteristics. 
The mean age did not differ significantly between 
the two groups, so there was no age-related 
bias. BMI was markedly higher in the asthma 
group.  
 
Table 1: Characteristics of subjects in the 
asthma and control groups 
 
Parameter Asthma Control 
Age (years) 12.5±2.3 12.8±2.5 
Sex (M:F) 28:31 29:28 
Weight (kg) 32.3±4.7 28.6±3.8 
BMI (kg/m2) 25.6±3.2 20.4±2.7 
BMI = body mass index 
 
TC, TG, LDL, and VLDL levels were significantly 
increased in the asthma group (30.12, 24.17, 
28.66, and 17.15 % higher than those of the 
controls, respectively; Table 2). As expected, 
there was a corresponding decrease in HDL level 
in the asthma group, which was 15.08 % lower 
than that of the controls. CETP activity was 13.54 
% higher in the asthma versus control group, and 
the difference was significant. LCAT activity was 
9.4 % higher in the asthma than in the control 
group, but the difference was not significant. 
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TAC was decreased by 33.33 % in the 
asthma group relative to the controls, 
while the serum MDA was increased by 
47.59 %, and the serum GSH was 
decreased by 12.09 %. 
 
Malondialdehyde (MDA) level was significantly 
higher (p ≤ 0.05) in asthma group. On the other 
hand, glutathione (GSH) levels was significantly 
lower in the asthma compared to the control 
groups. 
  
Table 2: Lipid profiles of the asthma and control 
groups. Values are means ± SD (units: mg/dL) 
 
Parameter Asthma Controls 
TC 189.63±16.56* 145.74±16.71 
HDL 42.39±5.42* 49.92±3.94 
TG 133.49±15.98* 107.51±11.38 
VLDL 26.23±2.65* 22.39±2.14 
LDL 108.55±9.38* 84.37±10.27 
TC, total cholesterol; HDL, high-density 
lipoprotein; TG, triglycerides; VLDL, very-low-
density lipoprotein; LDL, low-density lipoprotein; 




Higher mitochondrial cholesterol levels 
can lead to impaired GSH transport 
across the mitochondrial membrane, 
inhibiting the removal of free radicals 
generated in mitochondria and the 
excessive accumulation of reactive 
oxygen species (ROS) [11]. This could 
result in mitochondrial DNA damage, 
loss of essential mitochondrial protein 
synthesis, and progressive respiratory 
dysfunction, in turn leading to many 
diseases [8]. In our study, the 
significantly elevated cholesterol and 
LDL and VLDL levels are clues to the 
role of the lipid profile and increased free 
radical generation in asthma. 
 
Ectopic expression of the α- and β-chains of ATP 
synthase in liver cells is essential for HDL 
catabolism [19]; disturbance in this expression 
could lead to disease. The low serum HDL 
cholesterol levels observed in the children in our 
study could be the reason for the initiation or 
development of asthma. 
 
Invasive and non-invasive interventions 
have been developed to increase HDL 
cholesterol, and decrease LDL 
cholesterol, in blood and to promote 
health. 
 
Cholesteryl ester transfer protein (CETP) 
and lecithin cholesterol acyl transferase 
(LCAT) are enzymes involved in HDL 
remodeling and metabolism [20]. CETP 
facilitates the exchange of TG with 
cholesteryl ester, or vice versa, between 
HDL and other lipoproteins, ultimately 
leading to lower HDL, and higher LDL 
and VLDL, levels [21]. The increased 
CETP activity in the asthma group in our 
study explains the occurrence of 
metabolic reactions that favor the 
production of lipoproteins other than 
HDL, which might in turn explain the 
elevated LDL and VLDL levels, and 
decreased HDL level, among the 
asthmatic children.  
TG is a vital molecule for determining the 
HDL level in blood. An increased blood 
TG level could cause the addition of TG 
molecules to HDL, leading to hydrolysis 
by hepatic lipase and a reduction in the 
blood HDL level [22]. LCAT esterifies 
cholesterol via an acyl group, derived 
preferably from HDL molecules [23]. 
Abnormal lipid molecules have been 
observed in the absence of LCAT activity 
[23]. In our study, the LCAT activity was 
increased slightly, albeit not significantly, 
in the asthma group. 
 
Free radicals, which generate ROS, are 
produced via electron transport in 
mitochondria, and by NADPH oxidase 
activity in neutrophils, monocytes and 
macrophages, molybdenum 
hydroxylase, and arachidonic acid 
metabolism, which reacts with metal 
prosthetic groups or iron-sulfur centers in 
proteins, causing loss of functionality 
[11,24].  
 
Various cell types initiate the antioxidant 
defense process via enzymatic and non-
enzymatic antioxidants [11]. In a 
biological system, the ratio between the 
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inter-convertible oxidized and reduced 
forms of a specific protein or molecular 
pair is used to evaluate the redox 
environment and its reducing capacity 
[24]. In the present study, the 
significantly lower TAC and GSH levels 
seen in asthmatic patients versus 
controls support previous reports of 
increased MDA levels. GSH may be 
present in high concentrations in blood 
and the lungs.  
 
Lung epithelium contains 300 
micromoles of GSH, more than 90 % of 
which is in reduced form [25]. The 
importation of reduced GSH into cells, 
and exportation of oxidized GSH, could 
contribute to a reduction in oxidative 
stress [12]. In the present study, the 
lower GSH levels in the blood of the 
asthma subjects might have been 
insufficient for transport into the lungs, 
which could lead to the initiation and 
development of asthma. The data 
support the hypothesis that ROS and 
reactive nitrogen species (RNS) are 
responsible for the inflammation (via the 
the accumulation of inflammatory cells), 
airway obstruction, and hyper-
responsiveness seen in asthma [26], 
while ROS-mediated modifications in 
oxidation have been linked with asthma 
severity [27]. 
 
As our subjects were young, and thus 
had a high basal metabolic rate and level 
of physical activity, their tidal volume 
might also be high. An abundance of 
oxygen in the lungs could be responsible 
for adding more ROS and RNS to the 
reactive radicals produced metabolically 
[11]. This could worsen asthma still 
further, if not balanced by the removal of 
radicals via interventions based on 




Lipid-related complications might pre-
initiate disease, which could lead to 
asthma and many other related 
disorders. Although a clear connection 
between antioxidative capacity and 
asthma in obese children has been 
established, more work is needed to 





We established clear connections among 
asthma, the lipid profile, and antioxidant defense 
in obese children. The TC, TG, LDL, and VLDL 
levels, and LCAT and CETP activities, were 
significantly higher in our asthma versus control 
group. The asthmatic patients also suffered from 
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